Visual Function After Implantation of Bilateral AcrySof ReSTOR Aspheric +3

Alcon Research1 site in 1 country218 target enrollmentSeptember 2007

ConditionsCataract

Overview

Phase: Phase 4
Intervention: Not specified
Conditions: Cataract
Sponsor: Alcon Research
Enrollment: 218
Locations: 1
Primary Endpoint: Uncorrected Visual Acuity (UCVA)
Status: Completed
Last Updated: 16 years ago

Overview Investigators Eligibility Criteria Outcomes Sites Similar Trials

Overview

Brief Summary

A prospective evaluation of the visual parameters in a series of patients bilaterally implanted with AcrySof ReSTOR +3 Intraocular Lens (IOL).

Registry

clinicaltrials.gov

Start Date

September 2007

End Date

May 2009

Last Updated

16 years ago

Study Type

Interventional

Study Design

Single Group

Sex

All

Investigators

Sponsor

Alcon Research

Eligibility Criteria

Inclusion Criteria

•Diagnosed with cataracts

Exclusion Criteria

•Pre-existing conditions that could skew the results or are contraindications for the ReSTOR intraocular lens;
•\<1 diopter astigmatism by keratometry readings.

Outcomes

Primary Outcomes

Uncorrected Visual Acuity (UCVA)

Time Frame: 6 months

Uncorrected Visual Acuity (UCVA) measured by means of logMAR at various distances (40 centimeters (cm), 50 cm, 60 cm, 70 cm, and 4 meters (m)). Visual Acuity (VA) is measured in logMAR. LogMAR is the "logarithm of the minimum angle of resolution". A lower logMAR value indicates better visual acuity.